PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW127551View Pathway |
drug action
Cefmetazole Action PathwayEscherichia coli (strain K12)
|
Creator: Karxena Harford Created On: May 01, 2023 at 12:41 Last Updated: May 01, 2023 at 12:41 |
PW144402View Pathway |
drug action
Cefmetazole Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:34 Last Updated: October 07, 2023 at 13:34 |
PW176943View Pathway |
drug action
Cefonicid Action PathwayEscherichia coli
Cefonicid is a second-generation cephalosporin administered intravenously or intramuscularly. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections. Cefonicid exhibits an anti-bacterial mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145376View Pathway |
drug action
Cefonicid Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:41 Last Updated: October 07, 2023 at 15:41 |
PW175993View Pathway |
Cefonicid Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cefonicid are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:04 Last Updated: November 29, 2023 at 13:04 |
PW176944View Pathway |
drug action
Cefoperazone Action PathwayEscherichia coli
Cefoperazone is a broad-spectrum cephalosporin antibiotic used for the treatment of bacterial infections in various locations, including the respiratory tract, abdomen, skin, and female genital tracts. Cefoperazone exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs). Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:18 Last Updated: January 02, 2024 at 09:18 |
PW145377View Pathway |
drug action
Cefoperazone Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 15:42 Last Updated: October 07, 2023 at 15:42 |
PW175994View Pathway |
Cefoperazone Predicted Metabolism Pathway newHomo sapiens
Metabolites of Cefoperazone are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 13:05 Last Updated: November 29, 2023 at 13:05 |
PW176958View Pathway |
drug action
Ceforanide Action PathwayEscherichia coli
Ceforanide is a 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics.5 It was first authorized for use in the US in November 2001 and in Europe in April 2002. Shown to be effective against a wide range of Gram-positive and Gram-negative aerobic and anaerobic bacteria, ertapenem is used to treat various bacterial infections. Ceforanide exhibits a bactericidal mode of action. It works by binding to and inhibiting bacterial penicillin-binding proteins (PBPs).5 In Escherichia coli, it has a strong affinity toward PBPs 1a, 1b, 2, 3, 4 and 5 with preferential binding to PBPs 2 and 3.5 Upon binding to PBPs, ertapenem inhibits bacterial cell wall synthesis by interfering with the lengthening and strengthening of the peptidoglycan portion of the cell wall, thereby inhibiting cell wall synthesis.
|
Creator: Karxena Harford Created On: January 02, 2024 at 09:20 Last Updated: January 02, 2024 at 09:20 |
PW145024View Pathway |
drug action
Ceforanide Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:56 Last Updated: October 07, 2023 at 14:56 |